UAE · legal and regulatory

What is legal in the UAE, and what Panya will route.

MOHAP (Ministry of Health and Prevention) classifies tirzepatide and semaglutide as prescription-only medicines federally. DHA (Dubai Health Authority) licenses Dubai providers, DOH (Department of Health Abu Dhabi) licenses Abu Dhabi providers, MOH UAE licenses elsewhere. Mounjaro and Wegovy are both registered for UAE prescribing. Research peptides are prescription-only by default and customs has tightened on courier-imported pharmaceuticals through 2025.

What is legal in the UAE

Three routes that stay on the right side of the line.

Route 1

Local prescribing through a DHA / DOH / MOH-UAE-licensed clinic

NMC, Mediclinic, Cleveland Clinic Abu Dhabi, Aster, and the major insurance-affiliated networks all prescribe Mounjaro and Wegovy. Cost runs AED 900 to 1,800 per month at private clinics for the standard 5 to 10 mg dose. Insurance coverage varies meaningfully: some Daman, AXA, and ADNIC plans cover GLP-1s for documented T2D and refuse for weight loss; private comprehensive plans sometimes extend to weight management with prior authorisation.

Route 2

Personal-use import with documentation

Up to 3 months supply travels without prior approval IF you have (a) original packaging with your prescription label visible, (b) an English-language doctor's letter on letterhead stating your name, the medication, dose, and intended duration of stay, and (c) the medication in carry-on, not checked. Dubai and Abu Dhabi airports rarely flag personal-use GLP-1 pens with this documentation. Sharjah and the smaller emirates are less consistent. Larger quantities or unusual dose strengths: file a personal-import declaration through the MOHAP controlled-medicines portal (5 business day approval).

Route 3

Travel and use abroad

If you spend time in Thailand, the UK, the US, or another country where Panya can route, the recommendation fits that country's rules. A legally purchased prescription medication brought back into the UAE as a personal-use supply (under Route 2) is the honest path. Bringing back a research-chem vendor's BPC-157 vial through the UAE is not. Panya will not route research-chem channels into any region; for the UAE specifically, customs scrutiny on courier-imported pharmaceuticals has tightened materially through 2025.

What Panya will not do from the UAE

No Telegram, no WhatsApp resellers, no courier-shipped research peptides.

UAE has prosecuted unlicensed pharmaceutical sellers under federal anti-counterfeit laws. The Telegram and WhatsApp channels that ship freezer-pack pens out of unlicensed Sharjah warehouses are real legal exposure for the buyer, not just the seller. Panya does not route to those channels from any region and absolutely does not route them into the UAE. Research peptides (BPC-157, dihexa, the non-GLP-1 catalog at panya.health/peptide) are documented for transparency; we do not yet route to vendors for them anywhere, and will not route them into the UAE under any framing.

What Panya will do from the UAE

Match you to a registered prescriber.

Take the quiz from a UAE IP and you get matched against the 11-signal rubric to a DHA, DOH, or MOH-UAE-licensed prescriber (depending on emirate). Insurance-coverage check, AED price band, prescriber-letter quality, and consultation depth are all in the audit. If you are travelling and want to bring a supply back, the match email also lays out the personal-import path with the documentation you actually need. We say where a vendor scores below the 70/100 routing threshold rather than skip-listing.

Sources

Where these rules live.

  • MOHAP (Ministry of Health and Prevention): mohap.gov.ae for the federal medicines register, prescription-only classification, and the controlled-medicines portal for personal-import declarations.
  • DHA (Dubai Health Authority): dha.gov.ae for Dubai-licensed providers including Dubai Healthcare City clinics.
  • DOH (Department of Health Abu Dhabi): doh.gov.ae for Abu Dhabi-licensed providers.
  • UAE Federal Customs Authority for medicine import rules governing personal-use carry-on quantities versus declared imports.
  • UAE Federal Decree-Law No. 18 of 2024 (anti-counterfeit medicines) under which unlicensed pharmaceutical sellers have been prosecuted.

Regulation can change. This page was last reviewed April 2026. If you spot a rule we have wrong, email partner@panya.health and we will correct it the same week.

We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.